Our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of our efforts to do that.
AstraZeneca is a major contributor to UK science and innovation investment, economic prosperity and to patient health.
The UK is home to our global headquarters and major research and development and manufacturing facilities.
We invest over £1.3 billion per year in research and development in the UK.